Surrozen, Inc. Common
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Flagged at $24.13 at 09:42 AM on Oct 08, then ran to $28.85 +20% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is SRZN up today? It is at $31.65 (+5.08%), and our scanner flagged it 136 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SRZN spikes, and full due diligence on SRZN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SRZN 136 times in the last 30 days. Create a free account to track $SRZN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SRZN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SRZN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSurrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 MillionReported be exercised on a cash or net exercise basis and have expiration dates ranging from March 2030 to October 2031. Substantially all outstanding common stock warrants have an exercise price of $11.54 per share., from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 22, 2026 · 13 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
1,988,072 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $50.0M in size · Priced at $25.15/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kutzkey Tim Director | Other | 1.55M 13.2% of company | added 69% | 3.81M | $18.0M at $11.60 | Oct 20, 26 |
Column Group Iii Gp, Lp Beneficial Owner (10%) | Other | 1.55M 13.2% of company | added 69% | 3.81M | $18.0M at $11.60 | Oct 20, 26 |
Tcg Crossover Gp Ii, Llc Beneficial Owner (10%) | Sold (automatic/other) | -325K 2.8% of company | sold 22% | 1.15M | $6.9M at $21.25 | Jul 22, 26 |
Parker Craig C Officer | Acquired (grant/award) | +2K 0.01% of company | added 9.8% | 18K | $13K at $8.11 | Jun 15, 26 |
Williams Charles O Officer | Acquired (grant/award) | +2K 0.01% of company | added 10% | 18K | $14K at $8.11 | Jun 15, 26 |
Li Yang Officer | Acquired (grant/award) | +2K 0.01% of company | added 9.7% | 19K | $14K at $8.11 | Jun 15, 26 |
Maleki Andrew Pedrum Officer | Acquired (grant/award) | +607 | n/a | 607 | $12K at $19.01 | Jun 15, 26 |
Parker Craig C Officer | Sold (automatic/other) | -5K 0.04% of company | sold 21% | 17K | $151K at $33.33 | May 4, 26 |
Williams Charles O Officer | Sold (automatic/other) | -2K 0.02% of company | sold 11% | 17K | $68K at $33.33 | May 4, 26 |
Li Yang Officer | Sold (automatic/other) | -2K 0.01% of company | sold 8.4% | 17K | $53K at $33.33 | May 4, 26 |
Parker Craig C Officer | Other | 13K 0.1% of company | added 100% | 21K | n/a | May 1, 26 |
Williams Charles O Officer | Other | 6K 0.05% of company | added 43% | 19K | n/a | May 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on SRZN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SRZN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SRZN last traded at $31.65, up 5.08% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Surrozen, Inc. Common (SRZN) is next expected to report earnings on Friday, November 6, 2026, which is tomorrow. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SRZN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SRZN 136 times in the last 30 days.
SRZN (Surrozen, Inc. Common) trades on XNAS, with a market cap of about $372M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SRZN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SRZN discussion
Sign in to ask a question or join the discussion.